#Ambulatory Cardiac Monitoring Devices Market Share

[industrynewsupdates]

Ambulatory Cardiac Monitoring Devices Market Key Players, Revenue And Growth Rate

The Africa mobile air compressor market size is expected to reach USD 362.2 million by 2030, registering a CAGR of 3.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing need for energy-efficient mobile air compressors, together with the rising demand for low-cost mobile air compressors, will drive this growth over the forecast period. For instance, Doosan Portable Power South Africa offers a technologically advanced line of portable/mobile air compressors.

To encourage end customers to choose next-generation products, prominent manufacturers are producing eco-friendly and low-maintenance systems. To differentiate their goods in a highly competitive industry, manufacturers such as Ingersoll Rand Plc, Cook Compression, and Atlas Copco Inc. have developed technologically advanced systems with high-performance capabilities. These mobile air compressors provide advantages such as higher efficiency and lower noise levels.

These aforementioned factors will drive market demand during the projected timeframe. Cook Compression, for instance, announced two new Authorised Service Partners in August 2020 to provide compressor valve and package case repairs. Fancraft Ltd. will serve South Africa, Namibia, Mozambique, and Botswana, while WoodServ will serve the Middle East and Pakistan.

Saudi Arabia has gained a significant part of market revenue as a result of government efforts such as Saudi Vision 2030 and the National Transformation Plan 2020, which aim to accelerate economic growth and diversification by establishing new industrial units around the country. For instance, Howden acquired Compressor Products International in December 2021. This acquisition has enabled the former to expand its market footprint in Asia Pacific and South Africa. These aforementioned factors are anticipated to augment the Africa mobile air compressor in the coming years.

The Democratic Republic of the Congo (DRC) has huge untapped cobalt, gold, and high-grade copper reserves, according to the International Trade Administration. For instance, the DRC was the world's greatest cobalt miner in 2020, producing 95,000 tonnes, or roughly 41% of the world's cobalt. Furthermore, in 2021, mining resource production expanded from 10,000 tonnes to approximately 1 million.

Gather more insights about the market drivers, restrains and growth of the Africa Mobile Air Compressor Market

Africa Mobile Air Compressor Market Report Highlights

• The rotary segment is estimated to witness a CAGR of 3.4% over the forecast period. This growth is ascribable to the extensive adoption of this technology in heavy industrial applications such as mining, pharmaceutical, oil & gas, and manufacturing. Furthermore, since these compressors require less maintenance and are simple to operate, their popularity in low-duty applications is growing

• The oil filled air compressor segment led the market and accounted for 68.3% of the global revenue share in 2024.

• The electric segment led the market with a revenue share of 63.5% in 2024 owing to the compact and versatile design. Moreover, an electric mobile air compressor has many potential advantages over diesel mobile air compressors such as no CO2, less maintenance cost, production of better quality compressed air, enhanced safety, and the increasing reliability & uptime

• According to the International Labour Organization (ILO), mining is one of Zambia's primary sources of formal employment. Copper mining, for instance, has drawn significant foreign investment and experienced rapid growth over the last decade. It has consistently drawn a sizable proportion of foreign direct investment. The mining industry's expansion in Zambia will drive demand for mobile air compressors in the coming years

• According to the International Trade Administration, the oil & gas industry received approximately 75% of Egypt's foreign direct investment (FDI). In the coming years, the burgeoning oil & gas industry in Egypt, and particularly in Africa, will drive demand for mobile air compressors. Workers in the oil & gas industry, for instance, require mobile air compressors to power devices at various onshore & offshore drilling sites. The machines are also used to install reactor rods and operate coolant and steam circuit valves

Africa Mobile Air Compressor Market Segmentation

Grand View Research has segmented the Africa mobile air compressor market based on technology, lubrication, power, end use, and country:

Africa Mobile Air Compressor Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Rotary

• Reciprocating

Africa Mobile Air Compressor Lubrication Outlook (Revenue, USD Million, 2018 - 2030)

• Oil Free

• Oil Filled

Africa Mobile Air Compressor Power Outlook (Revenue, USD Million, 2018 - 2030)

• Diesel

• Electric

Africa Mobile Air Compressor End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Construction

• Mining

• Water Well Drilling

• Oil & Gas

• Rental/Plant

• Manufacturing

• Others

Africa Mobile Air Compressor Country Outlook (Revenue, USD Million, 2018 - 2030)

• Africa

o Zambia

o Malawi

o Congo DRC

o South Africa

o Egypt

List Of Key Players in the Africa Mobile Air Compressor Market

• Atlas Copco

• Doosan

• ELGI EQUIPMENTS LIMITED

• Kirloskar

• Sandvik

• Ingersoll Rand

• Sullair (Hitachi, Ltd)

• Kaeser

• Airstream

• Trade Air

• CompAir

Order a free sample PDF of the Africa Mobile Air Compressor Market Intelligence Study, published by Grand View Research.

[mitalipingale]

https://sparktv.net/read-blog/38734_ambulatory-cardiac-monitoring-devices-market-share-overview-competitive-analysis.html

The Ambulatory Cardiac Monitoring Devices Market in 2023 is US$ 6.38 billion, and is expected to reach US$ 7.79 billion by 2031 at a CAGR of 10.60%.

[lalsingh228-blog]

Ambulatory Cardiac Monitoring Devices Market May Set New Growth Story

Advance Market Analytics added research publication document on Worldwide Ambulatory Cardiac Monitoring Devices Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Ambulatory Cardiac Monitoring Devices market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2022 which is estimated and forecasted till 2028*. Some are the key & emerging players that are part of coverage and have being profiled are Medtronic (Ireland), Boston Scientific (Unites States),,  Abbott Laboratories (Unites States),,  GE Healthcare (United States),,  BIOTRONIK (Germany), ,  Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), Micro port scientific corporation (United States), NUUBO Smart Solutions Technologies, SL(Spain), Koninklijke Philips N.V (Netherlands), Welch Allyn – A Hill-Rom Inc.(United States), Spacelabs Healthcare, Inc (United States), Nihon Kohden Corporation (Japan), Fukuda Denshi Co, Ltd( Japan), Biotelemetry, Inc (United States), AliveCor, Inc (Unites States), Biotronik, Inc (Germany), Medronic, Plc (Ireland), St. Jude Medical, LLC (United States). Get free access to Sample Report in PDF Version along with Graphs and Figures @ https://www.advancemarketanalytics.com/sample-report/180230-global-ambulatory-cardiac-monitoring-devices-market

Ambulatory monitors are devices that are used to record the electrical activity of the human heart. Ambulatory monitors are used to detecting heart rhythm problems for longer periods of time. These monitor devices help to detect the heart with increased detection time and with more precise results as compared to traditional heart monitors. Ambulatory cardiac monitoring devices are used to assist doctors with irregular cardiac arrhythmias which occur only sporadically and unpredictably. Geographically, North America is leading in terms of revenue part from the region which can be attributed to an increase in government and private funding and a large volume of tests for cardiac diseases is performed especially in this region. Ambulatory Cardiac Monitoring Devices are used to monitor patients with syncope or for infrequent rhythm abnormalities and for long-term monitoring of atrial fibrillation post-ablation. Hence this is the key factor that is triggering the market over the forecast period.

Keep yourself up-to-date with latest market trends and changing dynamics due to COVID Impact and Economic Slowdown globally. Maintain a competitive edge by sizing up with available business opportunity in Ambulatory Cardiac Monitoring Devices Market various segments and emerging territory. Influencing Market Trend

The wireless ECG monitors can be used for the continuous monitoring of patients suffering from CVD and for the detection of problems when they are usually easier to treat while avoiding life-threatening and expensive emergency admissions.

Market Drivers

It helps to record patient heart rhythm and blood flow regulation in the human body

Opportunities:

Ambulatory monitors are devices is used to record the electrical activity in the human heart.

 

Challenges:

large amount skilled labour is required

Have Any Questions Regarding Global Ambulatory Cardiac Monitoring Devices Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/180230-global-ambulatory-cardiac-monitoring-devices-market Analysis by Type (ECG device, Holter Monitor, Event monitor, Others), End use (Hospitals, Ambulatory Surgical Centre, Diagnostic Centre, Homecare Settings, Emergency Medical service)

Competitive landscape highlighting important parameters that players are gaining along with the Market Development/evolution

• % Market Share, Segment Revenue, Swot Analysis for each profiled company [Medtronic (Ireland), Boston Scientific (Unites States),,  Abbott Laboratories (Unites States),,  GE Healthcare (United States),,  BIOTRONIK (Germany), ,  Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), Micro port scientific corporation (United States), NUUBO Smart Solutions Technologies, SL(Spain), Koninklijke Philips N.V (Netherlands), Welch Allyn – A Hill-Rom Inc.(United States), Spacelabs Healthcare, Inc (United States), Nihon Kohden Corporation (Japan), Fukuda Denshi Co, Ltd( Japan), Biotelemetry, Inc (United States), AliveCor, Inc (Unites States), Biotronik, Inc (Germany), Medronic, Plc (Ireland), St. Jude Medical, LLC (United States)]

• Business overview and Product/Service classification

• Product/Service Matrix [Players by Product/Service comparative analysis]

• Recent Developments (Technology advancement, Product Launch or Expansion plan, Manufacturing and R&D etc)

• Consumption, Capacity & Production by Players The regional analysis of Global Ambulatory Cardiac Monitoring Devices Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Whereas, owing to rising no. of research activities in countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate the forecast period 2023-2028.

Table of Content Chapter One: Industry Overview Chapter Two: Major Segmentation (Classification, Application and etc.) Analysis Chapter Three: Production Market Analysis Chapter Four: Sales Market Analysis Chapter Five: Consumption Market Analysis Chapter Six: Production, Sales and Consumption Market Comparison Analysis Chapter Seven: Major Manufacturers Production and Sales Market Comparison Analysis Chapter Eight: Competition Analysis by Players Chapter Nine: Marketing Channel Analysis Chapter Ten: New Project Investment Feasibility Analysis Chapter Eleven: Manufacturing Cost Analysis Chapter Twelve: Industrial Chain, Sourcing Strategy and Downstream Buyers Read Executive Summary and Detailed Index of full Research Study @ https://www.advancemarketanalytics.com/reports/180230-global-ambulatory-cardiac-monitoring-devices-market Highlights of the Report • The future prospects of the global Ambulatory Cardiac Monitoring Devices market during the forecast period 2023-2028 are given in the report. • The major developmental strategies integrated by the leading players to sustain a competitive market position in the market are included in the report. • The emerging technologies that are driving the growth of the market are highlighted in the report. • The market value of the segments that are leading the market and the sub-segments are mentioned in the report. • The report studies the leading manufacturers and other players entering the global Ambulatory Cardiac Monitoring Devices market. Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia. Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[marketingreportz]

Emergency Medical Services Products Market Opportunity Analysis & Industry Forecast, 2024–2030

Emergency Medical Services Products Market Overview:

Request sample :

A major trend in the market in telemedicine. The integration of telemedicine into EMS allows for remote patient monitoring, virtual consultations, and real-time data sharing, improving patient care and reducing response times. Another trend in the market is the increasing focus on health leading to a number of devices such as pulse oximeters, bp monitors etc at home. When an unusual reading is spotted, the patient can call emergency medical services leading to better outcomes. The American Heart Association conducted a poll in association with by Elevance Health Foundation. The survey participants, patients with high blood pressure at clinics in under-resourced areas throughout the U.S., were provided with blood pressure kits to monitor their blood pressure at home as part of the Building Healthier, Safer Communities Together initiative supported. About 88% of the participants said that they planned to check their blood pressure levels at least once daily, and 64% of the respondents said they believe that monitoring their blood pressure at home will help to improve their overall health.

Emergency Medical Services Products Market — Report Coverage:

The “Emergency Medical Services Products Market Report — Forecast (2024–2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Emergency Medical Services Products Market.

AttributeSegment

By Mode of Service

Ground Ambulance

Air Ambulance

Water Ambulance

By Service Type

Basic Life Support (BLS)

Advanced Life Support (ALS)

Others

By Type

Life Support and Emergency Resuscitation Equipment

Patient Monitoring Systems

Patient Transport Equipment

Wound Care Products

IV Supplies

Personal Protective Equipment (PPE)

Others

By Application

Cardiac Care

Trauma Injuries

Respiratory Care

Others

By End User

Hospitals and Trauma Centers

Ambulatory Surgical Centers

Fire Departments and Public Safety Agencies

Military and Defense

Home Care Settings

Others

By Geography

North America (U.S., Canada and Mexico)

Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe),

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific),

South America (Brazil, Argentina, Chile, Colombia and Rest of South America)

Rest of the World (Middle East and Africa).

COVID-19 / Ukraine Crisis — Impact Analysis:

Inquiry Before Buying:

The outbreak of COVID-19 strained the emergency medical services EMS market. Hospitals were at their breaking point and EMS staff were in constant need. The immediate need for ventilators, masks and testing kits soared where patient management strategies had to be advanced rapidly. Due to the supply chain issues, most of the EMS products were in low supply especially in the initial days of the pandemic.

The Russia-Ukraine war affected the supply chains, leaving some without the critical equipment they needed. Due to high costs, it was difficult to source medical necessities since health facilities had less funding to spend on such products.

Key Takeaways:

APAC Leads the Market:

The APAC region held a major market share of 37% in 2023 due to pressing public health concerns, particularly road accidents and pollution-related illnesses. According to the Asian Development Bank, Asia and the Pacific record 645,000 road accident fatalities annually, with nearly 3.5 million deaths in the past five years. This high incidence of accidents, coupled with the rising burden of respiratory and cardiovascular diseases caused by severe air pollution in countries like India, China, Bangladesh and Pakistan is driving demand for reliable EMS products. Healthcare systems are struggling to cope, leading governments and healthcare providers to invest heavily in EMS infrastructure. This urgent need for advanced EMS products, faster response times, and well-equipped ambulances is propelling the rapid market growth in Asia-Pacific.

Respiratory Care is the Fastest Growing

The segment of respiratory care in the Emergency Medical Services Products Market is the fastest growing, this growth can be attributable to the increasing frequencies of respiratory diseases associated with pollution. As noted by the World Bank, small particulate matter (PM2.5) from air pollution affects diseases including Chronic Obstructive Pulmonary Disease (COPD), lung cancer and pneumonia. These problems are worst in the developing countries where individuals are subjected to high pollution rates every day. In fact, around 6.4 million people every day die due to these tiny particles floating in the air. Moreover, the expenses incurred due to pollution borne health problems are enormous which is estimated to be $8.1 trillion annually; this is about 6.1% of the global Gross Domestic Product (GDP). As the cases of respiratory emergencies are rising, the need for such equipment as ventilators and other products that are used by EMS services is increasing significantly. These devices are essential in emergency responses, further driving growth in this segment, especially in regions heavily impacted by air pollution.

Schedule A Call :

Life Support and Emergency Resuscitation Equipment is the largest segment

The largest segment of the Emergency Medical Services Products Market is generally Life Support and Emergency Resuscitation Equipment because of the growing need and application for intensive care in emergency cases. Among these, cardiovascular diseases which impact over 640 million people globally now are the primary driving force for this demand as indicated by the British Heart Foundation’s September 2024 report. Heart and circulatory diseases alone affect 1 in 12 people in the world, which is why there is a rise in demand for technologies such as defibrillators and ventilators. Also, according to WHO, road traffic injuries are the leading cause of death among children and young persons between the ages of 5 and 29 representing a large population that requires emergency resuscitation and life support tools.

Growing Prevalence of Chronic Diseases Drives the Market

One of the key factors that have been fueling the growth of the market is the rise in the cases of chronic diseases in the global population. Chronic diseases like cardiovascular diseases and chronic respiratory diseases are conditions that may call for immediate medical attention hence boosting the need for more sophisticated EMS products. Since chronic diseases are characterized by acute events, the use of emergency care is significant. Citing the World Health Organization, cardiovascular diseases are known to cause 17.9 million lives every year, and chronic cardiovascular diseases alone is responsible for the death of over 4.1 million people annually. This increasing tendency places a great deal of load on healthcare systems and hence causing an increased spending on EMS equipment such as defibrillators, ventilators, and other related products for managing these crises. When the number of patients with chronic diseases increases, the need for timely and effective emergency care increases as well.

Buy Now:

Shortage of EMS Staff

The EMS industry is experiencing a severe shortage of skilled workers particularly paramedics and EMTs. As per Kentucky Board of Emergency Medical Services, Kentucky has an attrition rate of 21%, which means two out of 10 of their emergency medical technicians, commonly known as EMTs, will not return or certify again in 2025. Further, only 40% of their EMTs work with an EMS service. The demanding nature of the job characterized by long hours, irregular shifts and exposure to high-stress situations makes it increasingly difficult to attract and retain skilled professionals. Coupled with this, the relatively low compensation compared to other healthcare professions further discourages potential recruits. The increasing complexity of medical procedures and the rapid advancement of technology require a higher level of specialized training and certification. Additionally, several emergency workers died due to the pandemic leading to severe shortages in several parts of the world. More than 3,600 US healthcare workers died in the first year of the pandemic according to Lost on the Frontline, a 12-month investigation by the Guardian and Kaiser Health News (KHN).

Key Market Players:

Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the Emergency Medical Services Products Market. The top 10 companies in this industry are listed below:

Medtronic

Stryker Corporation

Philips Healthcare

Cardinal Health

ZOLL Medical Corporation

GE Healthcare

Ferno-Washington, Inc.

Ambu A/S

3M Health Care

Honeywell International Inc.

For more Lifesciences and Healthcare Market reports, please click here

[anujmrfr]

Temporary Cardiac Pacing Wires and Lead Market Size, Growth Outlook 2035

The global Temporary Cardiac Pacing Wires Lead Market Size was estimated at 1.49 (USD Billion) in 2024. The Temporary Cardiac Pacing Wires Lead Market Industry is expected to grow from 1.60 (USD Billion) in 2025 to 3.13 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.73% during the forecast period (2025 - 2034)

Market Overview

The Temporary Cardiac Pacing Wires and Lead Market is experiencing significant growth, driven by the rising incidence of cardiovascular diseases (CVDs), arrhythmias, and heart blockages. Temporary cardiac pacing is a critical intervention used in emergency settings, post-cardiac surgery, and for managing bradyarrhythmias. The increasing adoption of minimally invasive cardiac procedures, technological advancements in pacing leads, and the growing elderly population are key factors propelling market expansion.

Market Size and Share

The global Temporary Cardiac Pacing Wires Lead MarketSize was estimated at 1.49 (USD Billion) in 2024. The Temporary Cardiac Pacing Wires Lead Market Industry is expected to grow from 1.60 (USD Billion) in 2025 to 3.13 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.73% during the forecast period (2025 - 2034), reaching USD Y billion by 2030. North America dominates the market, attributed to advanced healthcare infrastructure, high prevalence of heart diseases, and rising adoption of pacing devices. The Asia-Pacific region is expected to witness the fastest growth, fueled by an increasing geriatric population, improving healthcare access, and growing cardiac care awareness.

Market Drivers

Rising Prevalence of Cardiovascular Disorders: Increasing cases of heart failure, bradycardia, and conduction system disorders are driving demand.

Advancements in Temporary Pacing Technologies: The introduction of biocompatible, MRI-compatible, and leadless pacing systems is revolutionizing the market.

Increase in Cardiac Surgeries and Electrophysiology Procedures: Post-surgical pacing requirements boost the need for temporary pacing leads and wires.

Growing Adoption of Minimally Invasive Procedures: Surge in catheter-based pacing techniques and percutaneous interventions is accelerating market growth.

Challenges and Restraints

Risk of Infections and Complications: Potential lead dislodgement, infections, and vascular injuries pose challenges.

Short Lifespan of Temporary Pacing Leads: Frequent replacement needs limit long-term efficacy.

Stringent Regulatory Requirements: Compliance with FDA, CE, and ISO standards can delay product approvals.

Market Trends

Development of Leadless Temporary Pacemakers: Emerging wireless, battery-free pacing solutions enhance patient safety.

Integration of AI and Remote Monitoring: AI-driven cardiac rhythm monitoring and predictive analytics are transforming cardiac care.

Increase in Biodegradable and Bioabsorbable Leads: Reducing the need for extraction procedures and lowering complication risks.

Regional Analysis

North America: Largest market share due to high CVD prevalence, advanced hospital infrastructure, and robust R&D investments.

Europe: Growth supported by increasing healthcare spending and adoption of innovative pacing solutions.

Asia-Pacific: Fastest-growing market due to rising cardiovascular cases, government initiatives, and medical technology advancements.

Rest of the World: Moderate growth driven by improving healthcare access and rising awareness of cardiac interventions.

Segmental Analysis

By Product Type:

Unipolar Pacing Wires

Bipolar Pacing Wires

Pacing Leads

By Application:

Bradyarrhythmias

Heart Blocks

Post-Cardiac Surgery Pacing

By End-User:

Hospitals

Ambulatory Surgical Centers

Specialty Cardiac Centers

Key Market Players

Jude Medical

Medtronic

Braun Melsungen

Abbott Laboratories

Cook Medical

Teleflex

Recent Developments

Introduction of Leadless Temporary Pacemakers: Innovation in self-contained pacing devices for safer post-surgical interventions.

Strategic Collaborations Between Cardiac Device Manufacturers and Hospitals: Enhancing product development and clinical adoption.

Growing Investment in AI-Powered Cardiac Monitoring Solutions: Improving real-time ECG analysis and arrhythmia detection.

For more information, please visit us at marketresearchfuture.

[global-research-report]

Continuous Monitoring, Better Outcomes: The Surge in ECG Patch and Holter Monitor Demand

The global ECG patch and holter monitor market size is expected to reach USD 4.8 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 19.58% from 2023 to 2030. The Growing prevalence of cardiac arrhythmia, increasing demand for ambulatory monitoring devices, and technological advancements are likely to drive the market during the forecast period.

Recent technologies in ECG patch and Holter monitor market include ECG chip, which can be inserted in the body to record heart rhythms for a long duration; ECG data management solutions; and telemetry. ECG patch and Holter monitor are also used in noncardiology departments, such as electrophysiology labs and nursing & emergency departments, as well as management of respiratory disorders. Initiatives such as the Door-to-Balloon (D2B) time by the American College of Cardiology (ACC) and “Mission: Lifeline” by AHA are expected to drive demand for wireless solutions and 12-lead ECG devices.

COVID-19 pandemic has resulted in high burden on public health and health care delivery globally. The disease has major effects on cardiovascular system. A wide range of arrhythmias have been reported in patients, which complicate the course of COVID-19 due to the associated treatments. Due to the redistribution of health care resources, access to emergency services, such as reperfusion therapy, may be affected, based on severity of the diseases at a local level. Apart from obtaining EUA for innovative products, the market also witnessed strategies such as mergers & acquisitions focused on strengthening solutions offerings, including connected care and remote patient monitoring due to their increased demand during the COVID-19 pandemic. Acquisitions made by Philips of BioTelemetry in December 2020 and Capsule Technologies, Inc. in January 2021 are a few such events.

ECG Patch And Holter Monitor Market Report Highlights

In terms of product, the ECG patch segment held the largest share in 2022 and is expected to register the fastest growth over the forecast period. Acquisitions and partnerships & collaborations between device manufacturers & management service providers to facilitate better exchange of information are anticipated to boost market growth by simplifying ECG workflow and reducing complexity associated with custom integration.

On the basis of application, the diagnostics segment dominated the market in 2022. However, the monitoring segment is expected to register the fastest growth over the forecast period.

The manufacturers are engaging in activities such as mergers & acquisitions to strengthen their monitoring solutions portfolio in the market. In November 2021, Philips acquired Cardiologs, a French medical technology company. The acquisition will help the company make use of Cardiologs’ artificial intelligence model that can interpret data from various monitoring devices

ECG Patch And Holter Monitor Market Segmentation

Grand View Research has segmented the global ECG patch and holter monitor market based on product, application, end use, and region:

ECG Patch And Holter Monitor Product Outlook (Revenue, USD Million, 2017 - 2030)

ECG Patch

Holter Monitors

ECG Patch And Holter Monitor Application Outlook (Revenue, USD Million, 2017 - 2030)

Diagnostics

Monitoring

ECG Patch And Holter Monitor End Use Outlook (Revenue, USD Million, 2017 - 2030)

Hospitals & Clinics

Ambulatory Facilities

Others

ECG Patch And Holter Monitor Regional Outlook (Revenue, USD Million, 2017 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Norway

Sweden

Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

Latin America

Brazil

Mexico

Argentina

Middle East & Africa (MEA)

Saudi Arabia

South Africa

UAE

Kuwait

List of Key Players

Nissha Medical Technologies (NMT)

Medtronic plc

Hill-Rom

iRhythm Technologies, Inc.

Nihon Kohden Corporation

Koninklijke Philips N.V.

GE Healthcare

Fukuda Denshi Co., Ltd.

Spacelabs Healthcare

AliveCor, Inc.

Cardiac Insight Inc.

VitalConnect

LifeSignals, Inc.

Bardy Diagnostics, Inc.

Nasiff Associates, Inc.

Midmark Corporation

Lief Therapeutics, Inc.

Schiller AG

Order a free sample PDF of the ECG Patch And Holter Monitor Market Intelligence Study, published by Grand View Research.

[lifesciencesblogss]

Global Mobile Cardiac Telemetry Systems Market: Trends, Opportunities, and Challenges by 2031

The market for MCT Systems is currently growing very rapidly due to the prevalence of cardiovascular diseases, advances in technology, and increased usage of remote patient monitoring solutions. MCT systems allow continuous cardiac activity monitoring outside the clinical environment. This enables healthcare providers to take early interventions to improve patient outcomes.

In 2023, the size of the mobile cardiac telemetry systems market was at US$ 0.74 billion, and by 2031, it is expected to reach US$ 2.26 billion. Further, this is likely to gain a CAGR of 12.2% during 2023-2031.

Market Dynamics

There are several key growth enablers for the MCT systems market:

Increasing incidence of Cardiovascular Diseases: Cardiovascular diseases are the killers of the world. Full control over management of those conditions is quite possible due to early diagnosis and suitable time of treatment. MCTs can offer consistent, reliable, and accessible continuous monitoring of the heart.

Technological Advancements: Advanced technologies such as wireless communicationand miniaturized sensors have improved the functionality and usability of MCT systems. The advancement in technologies has led to more comfortable, smaller devices with improved data transmission capabilities.

Increasing Adoption of Remote Patient Monitoring: Remote patient monitoring is an effective and cost-efficient mode of healthcare delivery. MCT systems are part of the RPM solutions, which enables healthcare providers to monitor patients and intervene promptly in case of abnormalities.

Increasing Geriatric Population: The geriatric population has the ease of getting cardiac diseases. Since the population of elders is increasing, the requirement of cardiac monitoring systems, for instance, MCT, is expected to increase as well.

Market Segmentation

On Basis Of Technology •  Lead Based •  Patch Based

On Basis of End User •  Hospitals •  Ambulatory Surgical Centers •  Cardiac centers

On Basis of Region •  North America •  Europe •  Asia-Pacific •  South and Central America •  Middle East and Africa

Competitive Landscape

•  Israel Aerospace Industries IAI •  Northrop Grumman Corporation •  Yamaha Motorsports •  Aviation Industry Corporation of China AVIC •  UMS Skeldar •  UAVOS Inc •  Delft Dynamics •  Schiebel Group •  AeroVironment Inc •  Kaman Aerospace

Future Opportunities

The MCT systems market seems promising in the future. Several factors will drive its growth:

Integration with Artificial Intelligence (AI): AI analytics can be used to further enhance the interpretation of ECG data, which allows for earlier detection of a potential cardiac event and improved management of patients.

Wearable Devices: MCT capabilities can be integrated into wearable devices, such as smartwatches and fitness trackers, for continuous, non-intrusive cardiac monitoring.

Cloud-Based Solutions: It would provide cloud-based solutions offering secure data storage, remote access, and real-time monitoring of patient data.

Conclusion-

The MCT systems market will witness significant growth in the near future as cardiovascular diseases grow in incidence, technology advances, and the remote patient monitoring solution gains more acceptance. In this regard, the next generations of MCT systems are likely to find integration with other health technologies and therefore enhance patient care and outcomes.

Frequently Asked Questions-

Which is the largest regional market for Mobile Cardiac Telemetry Systems? Ans: - North America is the largest regional market for Mobile Cardiac Telemetry Systems.

Which are the top companies to hold the market share in the Mobile Cardiac Telemetry Systems market? Ans: - Medtronic, BioTelemetry Inc. Philips, Applied Cardiac Systems Inc., Medicomp Inc., Preventice Solutions Inc Boston Scientific Corporation, The Scottcare Corporation, Medicalgorithmics SA, Zoll Medical Corporation Asahi Kasei Group, Telerhythmics LLC, iRhythm Technologies Inc are the top companies to hold the market share.

What will be the growth rate of the market during the forecast period of 2023 to 2031? Ans: - The Market for Mobile Cardiac Telemetry Systems is expected to grow at a compound annual growth rate of 12.2% between the forecast period of 2023 to 2031.

How big is the Mobile Cardiac Telemetry Systems market? Ans: The size of the global Mobile Cardiac Telemetry Systems market was US$ 0.74 billion in the year 2023 and will rise to US$ 2.26 billion in 2031.

Which are the sub-segments of the Mobile Cardiac Telemetry Systems market? Ans: - The Mobile Cardiac Telemetry Systems market is classified into Technology, End User, and region.

About Us-

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.

[jayanthitbrc]

Global Electrocardiography (ECG) Disposable Medical Electrodes Market Analysis 2024: Size Forecast and Growth Prospects

The electrocardiography (ecg) disposable medical electrodes global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Electrocardiography (ECG) Disposable Medical Electrodes Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The electrocardiography (ECG) disposable medical electrodes market size has grown steadily in recent years. It will grow from $3.03 billion in 2023 to $3.17 billion in 2024 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to increasing use in ambulatory and homecare settings, increasing telemedicine and remote patient monitoring technologies, rising demand for infection control, increasing demand for miniaturization of medical devices, and growing health knowledge.

The electrocardiography (ECG) disposable medical electrodes market size is expected to see steady growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing number of elderly people, increasing incidence of cardiovascular disorders, increased need for efficient diagnostic instruments, rising demand for infection control, and rising healthcare expenditure. Major trends in the forecast period include technological advancements, innovative solutions in cardiac monitoring, product innovations, artificial intelligence (AI)-driven healthcare, and advancements in medical devices.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/electrocardiography-ecg-disposable-medical-electrodes-global-market-report

Scope Of Electrocardiography (ECG) Disposable Medical Electrodes Market The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Electrocardiography (ECG) Disposable Medical Electrodes Market Overview

Market Drivers - The increasing incidences of cardiovascular disorders are expected to propel the growth of the electrocardiography (ECG) disposable medical electrodes market going forward. Cardiovascular disorders, commonly referred to as cardiovascular disease (CVD), encompass a broad range of conditions that affect the heart and blood vessels. The common cardiovascular diseases are coronary artery disease (CAD), hypertension (high blood pressure), heart failure, arrhythmias, peripheral artery disease (PAD), cardiomyopathy, and more. The increasing cardiovascular disorder is due to several factors, such as physical inactivity, unhealthy diet, smoking, and genetic and biological factors. Electrocardiography (ECG) disposable medical electrodes offer a significant advantage by ensuring precise and reliable cardiac monitoring. Their single-use design minimizes the risk of cross-contamination, promoting patient safety while delivering consistent performance in both routine and emergency settings, thereby enhancing the overall quality of cardiovascular care. For instance, in July 2023, according to the Society For Cardiovascular Angiography And Interventions, a US-based organization, peripheral artery disease (PAD) affects 8-10 million Americans each year, and it is estimated that 19 million Americans would have peripheral artery disease (PAD by 2050. Therefore, the increasing incidence of cardiovascular disorder drives the electrocardiography (ECG) disposable medical electrodes market.

Market Trends - Major companies operating in the electrocardiography (ECG) disposable medical electrodes market are focused on developing innovative technologies such as conductive fabric technology that involves the integration of electrically conductive materials into textiles, allowing fabrics to conduct electricity. Conductive fabric technology consists of integrating electrically conductive materials into textiles, allowing fabrics to conduct electricity. These fabrics are typically made by weaving or embedding conductive fibers, threads, or coatings into traditional textiles. For instance, in December 2023, Nahtlos AG, a Switzerland-based Company, launched a medically certified Nahtlos Durastrip, an ECG Electrode patch for move sense sensors certified as MDR (EU 2017/745) class I Medical Device. The Durastrip utilizes a unique conductive fabric technology and a special humidification method. This design helps maintain adhesion and signal integrity over more extended periods of use, making it suitable for multi-day monitoring.

The electrocardiography (ECG) disposable medical electrodes market covered in this report is segmented –

1) By Type: Pre-Gelled Electrodes, Dry Electrodes, Wet Electrodes 2) By Technology: Electrochemical Technology, Printed Electronics 3) By Application: Cardiology, Ambulatory Monitoring, Holter Monitoring, Stress Testing

Get an inside scoop of the electrocardiography (ecg) disposable medical electrodes market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=19045&type=smp

Regional Insights - North America was the largest region in the electrocardiography (ECG) disposable medical electrodes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocardiography (ECG) disposable medical electrodes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Major companies operating in the electrocardiography (ECG) disposable medical electrodes market are Cardinal Health Inc., Koninklijke Philips N.V., GE HealthCare Technologies Inc., Medline Industries LP, ZOLL Medical Corporation, Nissha Medical Technologies Ltd., ConMed Corporation, Ambu A/S, BPL Medical Technologies, AD Instruments, Graham Partners Inc., Medico Electrodes International Limited, Narang Medical Limited, Vitalograph Ltd., Leonhard Lang GmbH, Bio-Protech Inc., Intelesens Ltd., Fazzini S.r.l., Danlee Medical Products Inc., LUMED Srl

Table of Contents 1. Executive Summary 2. Electrocardiography (ECG) Disposable Medical Electrodes Market Report Structure 3. Electrocardiography (ECG) Disposable Medical Electrodes Market Trends And Strategies 4. Electrocardiography (ECG) Disposable Medical Electrodes Market – Macro Economic Scenario 5. Electrocardiography (ECG) Disposable Medical Electrodes Market Size And Growth ….. 27. Electrocardiography (ECG) Disposable Medical Electrodes Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[farmacuticals]

The Role of Cardiac Output Monitoring Devices in Modern Healthcare

Cardiac Output Monitoring Devices are essential in healthcare for assessing and monitoring the heart's performance by measuring the amount of blood pumped by the heart per minute. These devices are particularly useful in intensive care units, during surgeries, and in emergency situations, providing real-time data that helps medical professionals make informed decisions about patient care. By monitoring cardiac output, these devices assist in diagnosing, managing, and treating conditions such as heart failure, shock, and other critical illnesses.

The Cardiac Output Monitoring Device Market Size was projected to reach 2.73 billion USD in 2022, according to MRFR analysis. It is anticipated that the market for cardiac output monitoring devices would increase from 2.85 billion USD in 2023 to 4.2 billion USD in 2032. During the projected period (2024-2032), the cardiac output monitoring device market is anticipated to increase at a CAGR of approximately 4.4%.

Size and Market Share of Cardiac Output Monitoring Device

The Cardiac Output Monitoring Device market has experienced steady growth over recent years due to an increasing prevalence of cardiovascular diseases, advances in healthcare technology, and the rising demand for minimally invasive monitoring techniques. The market size for these devices is significant and is projected to continue growing as healthcare providers worldwide emphasize enhanced patient monitoring and outcome optimization. The market share is currently dominated by a few major players, with new competitors entering as demand increases, particularly in regions like North America, Europe, and Asia-Pacific. This growth trajectory is supported by rising healthcare expenditures and the integration of artificial intelligence and machine learning for more precise data analysis in cardiac output monitoring.

Cardiac Output Monitoring Device Analysis

An analysis of the Cardiac Output Monitoring Device market reveals a diverse range of device types, including invasive, minimally invasive, and non-invasive technologies. Invasive devices, such as pulmonary artery catheters, have long been the standard, providing accurate measurements directly from the heart. However, minimally invasive and non-invasive devices, like ultrasound-based Doppler devices, have become increasingly popular due to lower associated risks and improved patient comfort. Key players in the industry are focused on enhancing device accuracy, reducing invasiveness, and ensuring data reliability, which is essential for clinical decision-making. This market analysis also shows that hospitals and diagnostic centers are the primary end-users, with increasing demand from ambulatory care centers and outpatient facilities as cardiac output monitoring technology becomes more portable and user-friendly.

Cardiac Output Monitoring Device Trends

The Cardiac Output Monitoring Device market is influenced by several key trends, including technological advancements, patient preference for non-invasive procedures, and the rise in chronic diseases such as hypertension and diabetes that impact cardiovascular health. Recent developments in digital health technology, such as wearable monitoring devices, are expected to revolutionize the market, offering a convenient option for continuous monitoring without hospital admission. Another significant trend is the integration of artificial intelligence, which allows for more precise data analysis, helping healthcare providers predict outcomes and improve patient management. Moreover, manufacturers are focusing on creating compact, portable devices that can be used in diverse healthcare settings, allowing for more widespread and accessible monitoring solutions.

Reasons to Buy Cardiac Output Monitoring Device Market Reports

Comprehensive Market Insights: Reports offer a detailed understanding of the global Cardiac Output Monitoring Device market, including size, share, trends, and growth projections.

Competitive Analysis: Gain valuable insights into the competitive landscape, identifying key players, recent developments, and potential areas for business expansion.

Technology and Innovation Insights: Stay updated on emerging trends in cardiac output monitoring technology, such as AI integration and portable device innovations.

Investment Opportunities: Understand investment potentials by analyzing market segments, geographical distribution, and demand across various healthcare settings.

Informed Decision Making: Access data-driven insights that help stakeholders make informed decisions regarding product development, marketing strategies, and partnerships.

Recent Developments in Cardiac Output Monitoring Devices

The Cardiac Output Monitoring Device market has witnessed recent advancements aimed at improving accuracy, ease of use, and patient outcomes. Leading companies are incorporating AI algorithms to enhance predictive capabilities, allowing for early detection of potential complications. Non-invasive cardiac output monitoring technologies have also evolved, with innovations such as wearable sensors that provide continuous data with minimal discomfort. Additionally, recent developments in wireless connectivity have enabled remote monitoring, allowing healthcare providers to track patient status from anywhere. With increasing demand, manufacturers are focusing on creating affordable and accessible devices to meet global healthcare needs, especially in low-resource settings. These advancements are set to further propel the growth of the Cardiac Output Monitoring Device market, providing healthcare systems with more effective tools to manage and monitor cardiovascular health.

Related reports:

algae supplements market

automated endoscopy reprocessor market

bacteriological testing market

Top of Form

Bottom of Form

[adityarana1687-blog]

Wearable Patch Market Size To Reach $15.71 Billion By 2030

The global wearable patch market size is valued at USD 15.71 billion in 2030 and is projected to grow at a CAGR of 7.9% from 2024 to 2030. Wearable Patch is attached to the skin and can be worn for a couple of hours to weeks. In recent years these patches have become more popular and are most widely used for drug delivery or patient monitoring, and sports. They are also used to deliver medication such as nicotine and to treat various chronic diseases. Various companies are investing in this technology to gain a competitive advantage.

The connected wearable patch segment accounted for the highest market share in 2019. It has wireless connectivity features that help in monitoring the health of patients and delivering drugs accordingly. The factors responsible for the growth of the segment are growing concern among people related to their health and the increasing aging population with chronic diseases. Also, technological developments to boost the connected wearable patch with more data accuracy and features are anticipated to bring new advanced opportunities for the market in the coming future.

Based on the application, the clinical segment shares the highest market during the estimated period. It helps to gather information on a regular basis and then transforms data to connected devices such as laptops and smartphones so that the physicians have access to a real-time, continuous flow of data, which can avert patient worsening.

North America held the highest revenue share of 35.5% in 2019 due to its rising aging population, technological improvement in electronic skin, and increasing investment in R&D. In addition, increasing collaborations between hospitals, academic institutions, and widespread R&D activities at the industrial and academic level and increase in the scope of biomedical applications, have fueled the market growth. Moreover, the presence of major players in the region contributed to market growth.

Request a free sample copy or view report summary: Wearable Patch Market Report

Wearable Patch Market Report Highlights

The connected wearable segment dominated the market in 2019 and accounted for a revenue share of around 76.3% owing to increasing demand for electronic skin in developing countries

The clinical segment is anticipated to register the fastest growth rate of 6.4% over the forecast period

The clinical segment accounted for the highest revenue share of 50.5% in 2019 and is anticipated to maintain its dominance due to increasing investment in R&D of the medical device

North America dominated the market and accounted for a revenue share of 35.5% in 2019. This can be attributed to the rapid increase in the development of smart patches to meet the growing demand for efficient healthcare in the country

Wearable Patch Market Segmentation

Grand View Research has segmented the global wearable patch market report on the basis of type, technology, application, end use and region 

Wearable Patch Type Outlook (Revenue, USD Million, 2018 - 2030)

Temperature Patch

Glucose Patch

Heart rate and ECG Patch

Others

Wearable Patch Technology Outlook (Revenue, USD Million, 2018 - 2030)

Regular Wearable

Connected Wearable

Wearable Patch Application Outlook (Revenue, USD Million, 2018 - 2030)

Clinical

Non-clinical

Wearable Patch End Use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals

Ambulatory Surgical Centers

Homecare Settings

Wearable Patch Region Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Wearable Patch Market

AliveCor, Inc

VivaLNK, Inc

Cardiac Insight Inc

VitalConnect

LifeSignals, Inc

L’Oreal Group

Dexcom, Inc

GENTAG, Inc

Abbott Laboratories

Koninklijke Philips N.V.

Sensium Healthcare Ltd

Leaf Healthcare, Inc

Qualcomm Technologies, Inc

[deshpandeisha]

Refurbished Medical Equipment Market Growth and Size for Strategic Decision-Making

The global refurbished medical equipment market size is expected to reach USD 45.81 Billion in 2032 and register a steady revenue CAGR of 11.8% during the forecast period, according to latest analysis by Emergen Research. Increasing preference for eco-friendly products is a major factor driving market revenue growth of. Benefits of used medical imaging equipment for environment must be emphasized.

The circular economy is supported by refurbishment, a sort of reuse and waste reduction that raises useful lifespan of medical imaging equipment from 5-7 to 10-14 years or even longer. Resources and energy required to produce new equipment are saved by refurbishment. It is critical from an environmental standpoint to maximize service life of imaging scanners due to energy and materials used throughout the production, safety testing, and regulatory compliance processes. For instance, improving Magnetic Resonance Imaging (MRI) scanners and extending their service life maximizes the return on initial investment of energy and materials.

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1748

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Refurbished Medical Equipment market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Block Imaging, Inc., Soma Tech INTL, Avante Health Solutions, Hilditch Group, EverX Pty. Ltd., Integrity Medical Systems, Inc., and Radiology Oncology Systems

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/refurbished-medical-equipment-market

Emergen Research has segmented the global Refurbished Medical Equipment market on the basis of type, application, end-use, and region:

Segments Covered in this report are:

Product Outlook (Revenue, USD Billion; 2019–2032)

Medical Imaging Equipment

Computerized Tomography (CT) Scanners

Magnetic Resonance Imaging (MRI) Machines

X-Ray Machines

Nuclear Imaging Systems

Ultrasound Systems

Other Medical Imaging Equipment

Operating Room & Surgical Equipment

Anesthesia Machines

Electrosurgical Units

Operating Room Tables & Lights

Surgical Displays

Other Operating Room & Surgical Equipment

Patient Monitors

Multi-Parameter Monitors

Fetal Monitors

Electrocardiography Devices

Pulse Oximeters

Mobile Cardiac Telemetry Devices

Non-Invasive Blood Pressure Monitors

Other Patient Monitors

Cardiology Equipment

Defibrillators

Heart-Lung Machines

Other Cardiology Equipment

Urology Equipment

Dialysis Machines

Lithotripsy Devices

Neurology Equipment

Electromyograph Machines (EMG) Machines

Electroencephalography (EEG) Machines

Intensive Care Equipment

Ventilators

Infant Incubators & Warmers

Intravenous Therapy Systems

Endoscopy Equipment

Other Medical Equipment

Application Outlook (Revenue, USD Billion; 2019–2032)

Diagnostic Applications

Cardiology

Urology

Neurology

Orthopedics

Physiology

Emergency Medicine

Oncology

Obstetrics/Gynecology

Other Diagnostic Applications

Therapeutic Applications

Cardiology

Urology

Neurology

Orthopedics

Physiology

Emergency Medicine

Oncology

Obstetrics/Gynecology

Other Therapeutic Applications

End-Use Outlook (Revenue, USD Billion; 2019–2032)

Hospitals

Diagnostic Imaging Centers

Ambulatory Care Centers

Other End-Use

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

Analysis and estimation of the Refurbished Medical Equipment Market size and share for the projected period of 2022-2030

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Refurbished Medical Equipment Market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1748

[industrynewsupdates]

Understanding Implantable Cardioverter Defibrillators Market: Trends and Growth Drivers

The global implantable cardioverter defibrillator market size is projected to reach USD 5.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 6.4% from 2024 to 2030. The growth can be attributed to various factors, including advancements in product technology, the increasing prevalence of sudden cardiac arrest, growing public awareness about cardiac health, and supportive policies by governments and healthcare organizations. These factors collectively drive the demand for cardioverter defibrillators and contribute to the overall market expansion.

The global demand for cardiac resynchronization therapy devices (CRT-Ds) and implantable cardioverter defibrillators (ICDs) is fueled by the increasing prevalence of cardiovascular diseases and other heart ailments. Sudden cardiac arrest (SCA) remains a significant cause of mortality, with a rising incidence and associated risk factors. Heart failure contributes significantly to global health challenges and drives the need for CRT-Ds and defibrillators. In addition, the prevalence of abnormal heart rhythms, especially in older adults and individuals with coronary artery disease (CAD), further boosts the demand for ICDs. These factors highlight the growing importance of CRT-Ds and ICDs in addressing cardiovascular conditions and improving patient outcomes.

The ICD market was negatively impacted by the COVID-19 pandemic. The suspension of elective surgeries and the focus on COVID-19 patients affected the market during the first quarter of 2020. However, the pandemic accelerated the adoption of telehealth, including remote monitoring for patients with arrhythmias. Guidelines released by the Heart Rhythm Society emphasized limiting in-person visits and promoting remote care. Biotronik capitalized on this trend by promoting its implantable CRM devices with home monitoring technology. Despite the growth in cardiovascular remote monitoring, limited reimbursement in specific regions including some EU countries hindered the overall market expansion. Approximately 13 surveyed countries still do not provide reimbursement for remote technologies in the context of heart failure management.

Request Free Sample PDF of Implantable Cardioverter Defibrillators Market Size, Share & Trends Analysis Report

Implantable Cardioverter Defibrillator Market Report Highlights

• Based on product type, the ICD market is classified into transvenous implantable cardioverter-defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillator segments (S-ICDs). The T-ICDs segment dominated the market in 2023 with a revenue share of 89.83%.

• Based on type, the ICD market is classified into single-chamber ICDs, dual-chamber ICDs, and biventricular devices segments. The biventricular devices segment dominated the market in 2023 with a revenue share of 44.33%.

• Based on NYHA Class, the market is classified into NYHA Class II and NYHA Class III. The NYHA Class II segment dominated the market with a 67.72% share in 2023 and is estimated to grow at the fastest CAGR of 6.6% during the forecast period.

• Based on end-use, the ICD market is classified into hospitals, ambulatory surgical centers, and others. The hospitals segment dominated the market with a share of 86.67% in 2023 and is estimated to grow at the fastest CAGR of 6.5% during the forecast period.

• In terms of region, the North America dominated the global  market and accounted for 41.4% of the total market share in 2023. North America has a well-developed, advanced healthcare infrastructure, including hospitals, clinics, and medical facilities.

Implantable Cardioverter Defibrillator Market Segmentation

Grand View Research has segmented the global implantable cardioverter defibrillator market based on product type, type, NYHA class, end-use, and region:

Implantable Cardioverter Defibrillator Product Type Outlook (Revenue, USD Million, 2018 - 2030)

• Transvenous Implantable Cardioverter-Defibrillators

• Subcutaneous Implantable Cardioverter Defibrillators

Implantable Cardioverter Defibrillator Type Outlook (Revenue, USD Million, 2018 - 2030)

• Single Chamber ICDs

• Dual Chamber ICDs

• Biventricular Devices

Implantable Cardioverter Defibrillator NYHA Class Outlook (Revenue, USD Million, 2018 - 2030)

• NYHA Class II

• NYHA Class III

Implantable Cardioverter Defibrillator End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers

• Others

Implantable Cardioverter Defibrillator Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Sweden

o Norway

o Denmark

• Asia Pacific

o China

o Japan

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa

o Saudi Arabia

o South Africa

o UAE

o Kuwait

List of Key Players of Implantable Cardioverter Defibrillator Market

• Abbott

• Medtronic

• BIOTRONIK SE & Co. KG

• Boston Scientific Corporation

• MicroPort Scientific Corporation.

• LivaNova PLC.

Order a free sample PDF of the Implantable Cardioverter Defibrillators Market Intelligence Study, published by Grand View Research.

[mitalipingale]

https://twikkers.nl/blogs/264634/Ambulatory-Cardiac-Monitoring-Devices-Market-Share-Overview-Competitive-Analysis-and

The Ambulatory Cardiac Monitoring Devices Market in 2023 is US$ 6.38 billion, and is expected to reach US$ 7.79 billion by 2031 at a CAGR of 10.60%.

[credenceresearchdotblog]

The Hemodynamic Monitoring System Market has witnessed significant growth in recent years, with steady expansion projected to continue over the forecast period. As of 2023, the market size stood at $1,631.62 million, reflecting a Compound Annual Growth Rate (CAGR) of 5.54%. The hemodynamic monitoring systems market has been experiencing significant growth over recent years, driven by the rising prevalence of cardiovascular diseases, advancements in technology, and an increasing aging population. Hemodynamic monitoring, the study of blood flow and its properties within the circulatory system, is crucial in managing and diagnosing various medical conditions. These systems provide vital information on cardiac function, fluid status, and vascular integrity, enabling healthcare professionals to make informed decisions regarding patient care.

Browse the full report at https://www.credenceresearch.com/report/hemodynamic-monitoring-systems-market

Market Dynamics

1. Rising Cardiovascular Diseases

Cardiovascular diseases (CVDs) are among the leading causes of death globally. According to the World Health Organization (WHO), CVDs account for nearly 17.9 million deaths annually. This alarming statistic underscores the necessity for effective monitoring and management of cardiovascular conditions. Hemodynamic monitoring systems play a pivotal role in this context, providing real-time data on cardiac output, blood pressure, and other critical parameters.

2. Technological Advancements

The market has witnessed a surge in technological advancements, leading to the development of more sophisticated and non-invasive monitoring systems. Traditional methods, such as pulmonary artery catheterization, are being supplemented or replaced by less invasive techniques like impedance cardiography (ICG) and bioreactance. These innovations not only enhance patient comfort but also reduce the risk of complications, thereby driving market growth.

3. Aging Population

The global population is aging at an unprecedented rate. The United Nations estimates that by 2050, the number of people aged 60 years and above will double, reaching around 2.1 billion. Aging is associated with a higher incidence of chronic diseases, including CVDs. Consequently, the demand for hemodynamic monitoring systems is expected to rise, as these systems are essential in managing the health of elderly patients.

Market Segmentation

1. By Product Type

The hemodynamic monitoring systems market is segmented into invasive and non-invasive monitoring systems. Invasive systems, such as pulmonary artery catheters and central venous pressure monitors, provide direct and accurate measurements but involve a higher risk of complications. Non-invasive systems, including ICG and Doppler ultrasound, are gaining popularity due to their safety and ease of use.

2. By End-User

End-users of hemodynamic monitoring systems include hospitals, ambulatory surgical centers, and home care settings. Hospitals dominate the market owing to the high volume of surgeries and critical care procedures requiring continuous hemodynamic monitoring. However, the home care segment is expected to witness substantial growth, driven by the increasing preference for home-based healthcare and advancements in portable monitoring devices.

Regional Insights

1. North America

North America holds a significant share of the hemodynamic monitoring systems market, primarily due to the high prevalence of cardiovascular diseases and the presence of well-established healthcare infrastructure. The region also benefits from favorable reimbursement policies and a high adoption rate of advanced technologies.

2. Europe

Europe follows closely, with countries like Germany, France, and the UK leading the market. The region's growth is attributed to the increasing geriatric population and a strong focus on healthcare innovation.

3. Asia-Pacific

The Asia-Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as improving healthcare infrastructure, rising healthcare expenditure, and growing awareness about cardiovascular diseases are driving the market. Countries like China, India, and Japan are at the forefront of this growth.

Competitive Landscape

The hemodynamic monitoring systems market is highly competitive, with several key players striving to enhance their market presence through product innovation, mergers, and acquisitions. Some of the prominent companies in the market include Edwards Lifesciences Corporation, Philips Healthcare, GE Healthcare, and ICU Medical, Inc.

These companies are focusing on developing advanced monitoring systems that offer greater accuracy, ease of use, and integration with electronic health records (EHRs). Additionally, strategic partnerships and collaborations are common strategies employed by market players to expand their product portfolios and geographic reach.

Future Outlook

The future of the hemodynamic monitoring systems market looks promising, with continuous advancements in technology and a growing emphasis on personalized medicine. The integration of artificial intelligence (AI) and machine learning (ML) in monitoring systems is expected to revolutionize the market by providing predictive analytics and improving patient outcomes.

Key Players:

Edwards Lifesciences Corporation

ICU Medical, Inc.

LiDCO Group plc

Deltex Medical Group plc

Cheetah Medical, Inc.

PULSION Medical Systems SE (acquired by Maquet Holding B.V. & Co. KG)

GE Healthcare

Philips Healthcare

Nihon Kohden Corporation

Siemens Healthineers AG

Segments

By Type

Invasive Hemodynamic Monitoring

Non-Invasive Hemodynamic Monitoring

By Product

Monitors

Consumables

By End User

Hospitals and Clinics

Ambulatory Surgical Centers

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/hemodynamic-monitoring-systems-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[anujmrfr]

Arrhythmia Monitoring Devices Market Size, Growth Outlook 2035

the arrhythmia monitoring devices market size was valued at USD 4.30 Billion in 2023. The Global Arrhythmia Monitoring Devices industry is projected to grow from USD 5.60 Billion in 2024 to USD 8.20 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.32% during the forecast period (2024 - 2032).

Executive Summary

The Arrhythmia Monitoring Devices Market is witnessing significant growth due to the rising prevalence of arrhythmic disorders, increased awareness of heart health, and technological advancements in diagnostic devices. These devices, which include electrocardiogram (ECG) monitors, wearable heart monitors, and implantable devices, are crucial for detecting, managing, and treating arrhythmias. With the demand for real-time monitoring and remote patient management, this market is expected to expand rapidly in the coming years.

Market Overview

Arrhythmia is a condition characterized by irregular heartbeats, which can lead to severe complications such as stroke or heart failure if left untreated as per the analysis conducted by Market Research Future (MRFR), the arrhythmia monitoring devices market size was valued at USD 4.30 Billion in 2023. The Global Arrhythmia Monitoring Devices industry is projected to grow from USD 5.60 Billion in 2024 to USD 8.20 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.32% during the forecast period (2024 - 2032).

Market Drivers

Growing Incidence of Arrhythmic Disorders: The increasing global burden of cardiovascular diseases and aging populations are leading to a higher incidence of arrhythmias, thus driving demand for diagnostic and monitoring devices.

Advancements in Wearable Devices: The rise of wearable ECG monitors, smartwatches, and mobile health devices that enable continuous heart monitoring is transforming the way arrhythmias are detected and managed.

Telemedicine and Remote Monitoring: The growing adoption of telemedicine and remote monitoring solutions is propelling the demand for arrhythmia monitoring devices that allow patients to be monitored outside of clinical settings.

Market Restraints

High Cost of Devices: The cost of advanced arrhythmia monitoring devices, especially implantable and wearable devices, can be a significant barrier to market penetration in developing regions.

Regulatory Barriers: The approval and regulatory processes for medical devices can be time-consuming and complex, potentially delaying the availability of new monitoring technologies in certain markets.

Lack of Skilled Professionals: The need for trained professionals to interpret arrhythmia data and manage patient care may limit the widespread adoption of advanced monitoring systems, particularly in regions with insufficient healthcare infrastructure.

Regional Analysis

North America: North America holds the largest market share, with the U.S. being the key contributor due to the high prevalence of heart diseases, advanced healthcare infrastructure, and the adoption of wearable health technologies.

Europe: Europe is witnessing strong market growth, especially in the UK, Germany, and France, where healthcare systems are increasingly focused on improving cardiovascular care and monitoring.

Asia-Pacific: The Asia-Pacific region is expected to see the fastest growth due to improving healthcare access, rising awareness of heart health, and increasing adoption of wearable devices in countries like Japan, China, and India.

Segmental Analysis

By Device Type:

Electrocardiogram (ECG) Monitors

Implantable Loop Recorders

Wearable Heart Monitors

Mobile ECG Devices

By Application:

Atrial Fibrillation

Ventricular Arrhythmias

Bradycardia

Tachycardia

By End-User:

Hospitals and Clinics

Homecare Settings

Ambulatory Surgical Centers

Diagnostic Laboratories

Key Market Players

Abbott Laboratories (US)

BioTelemetry Inc. (US)

Fukuda Denshi Co. Ltd (Japan)

Applied Cardiac Systems Inc. (US)

Medtronic plc (Ireland)

Recent Developments

Integration of AI: The integration of artificial intelligence (AI) and machine learning algorithms into arrhythmia monitoring devices is enhancing diagnostic accuracy and enabling faster detection of arrhythmic episodes.

Wearable Technologies Expansion: Companies like Apple, Fitbit, and Garmin have expanded their wearable ECG monitoring features, allowing consumers to track their heart health conveniently through smartwatches and fitness trackers.

Regulatory Approvals: Several arrhythmia monitoring devices, such as implantable loop recorders and wearable ECG monitors, have recently received regulatory approvals, further driving the market's growth.

For more information, please visit @marketresearchfuture

[industryinsightsandanalysis]

Smartphone-Connected Pacemaker Devices Market Current Analysis & Forecast by 2027

The global Smartphone-Connected Pacemaker Devices Market is projected to experience substantial growth by 2027, with a notable Compound Annual Growth Rate (CAGR) during the forecast period from 2021 to 2027. The increasing prevalence of heart failure and arrhythmia has driven the demand for advanced, smartphone-connected cardiac devices, known as pacemakers. These devices can track data and monitor patient health through wireless remote systems, indicating a significant market expansion in the coming years.

Several factors are driving this market, including the rising incidence of cardiovascular diseases and the increasing demand for connected medical devices. Growing consumer awareness and higher disposable incomes have also contributed to the market's growth. Moreover, advancements in pacemaker technology, such as multi-functional capabilities, are expected to further propel the market. Modern smart pacemakers utilize real-time EGM waveforms for monitoring and can be programmed to automatically record and store data when specific triggers are encountered. According to DiCardiology, approximately 3 million people worldwide had pacemakers in 2018, with around 600,000 new pacemakers implanted annually to treat bradycardia. The rising incidence of cardiovascular diseases, such as heart failure and stroke, is anticipated to boost the demand for smartphone-connected pacemakers.

For a comprehensive analysis of the market drivers, visit:  https://univdatos.com/report/smartphone-connected-pacemaker-devices-market

The COVID-19 pandemic significantly impacted the market, leading to a decline in demand due to lockdowns, trade suspensions, and the rescheduling of routine hospital operations. For example, the Journal of Arrhythmia reported a 73% reduction in pacemaker implants during the pandemic, along with a 78% decline in cardiovascular diagnoses and new pacemaker implants. However, the market has regained traction following the relaxation of COVID-19 restrictions.

The market is segmented by product type, with implantable and external pacemakers. In 2020, implantable pacemakers dominated the market due to their effectiveness in controlling heartbeats and their use in treating slow heart rates after heart attacks, surgeries, or medication overdoses. The market is also divided by type into MRI-compatible and conventional pacemakers. MRI-compatible pacemakers accounted for a major revenue share in 2020, as patients with heart conditions often require MRI scans to detect serious issues.

Application-wise, the market is segmented into Arrhythmia, Congestive Heart Failure, and others, with the Arrhythmia segment leading in 2020 due to the increasing prevalence of arrhythmia among the aging population. End-user segments include hospitals & cardiac centers, ambulatory surgical centers, and others. Hospitals & cardiac centers are expected to see significant growth due to their superior patient care and compensation offerings during surgeries.

For a sample report, visit: https://univdatos.com/request_form/form/438

The report also provides a detailed regional analysis, covering North America, Europe, Asia-Pacific, and the Rest of the World. North America led the market in 2020, driven by the presence of major companies and advanced healthcare infrastructure in the U.S. Key market players include Medtronic PLC, Boston Scientific Corporation, BIOTRONIK, LivaNova PLC, Abbott Laboratories, MEDICO SpA, Pacetronix, Osypka Medical, Inc., Lepu Medical Group, and Cook Medical. These companies have engaged in mergers, acquisitions, and partnerships to enhance their market presence in the smartphone-connected pacemaker devices sector.

Contact Us:

UnivDatos Market Insights

Email - contact@univdatos.com

Contact Number - +1 9782263411

Website -www.univdatos.com